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Abstract
Background: Intralipid® and heparin infusion results in increased blood pressure and autonomic abnormalities in 
normal and hypertensive individuals. 
Objective: To evaluate insulin sensitivity and the impact of Intralipid® and heparin (ILH) infusion on hemodynamic, 
metabolic, and autonomic response in patients with the indeterminate form of Chagas’ disease.
Methods: Twelve patients with the indeterminate form of Chagas’ disease and 12 healthy volunteers were evaluated.
Results: Baseline blood pressure and heart rate were similar in both groups. Plasma noradrenaline levels were slightly 
increased in the Chagas’ group. After insulin tolerance testing (ITT), a significant decline was noted in glucose in 
both groups. ILH infusion resulted in increased blood pressure in both groups, but there was no significant change in 
plasma noradrenaline. The low-frequency component (LF) was similar and similarly increased in both groups. The high-
frequency component (HF) was lower in the Chagas’ group. 
Conclusion: Patients with the indeterminate form of Chagas’ disease had increased sympathetic activity at baseline and 
impaired response to insulin. They also had a lower high-frequency component and impaired baroreflex sensitivity at 
baseline and during Intralipid® and heparin infusion. (Arq Bras Cardiol 2012;98(3):225-233)
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acids in the circulation. In Brazil, there is a large population 
with Chagas’ disease2 that presents different autonomic 
abnormalities related to sympathetic impairment. Sympathetic 
system injury is present in the peripheral organs and in the 
central nervous system. Consequently, these abnormalities 
have been considered as a model to analyze the response to 
acute challenges with different stimuli. Guariento et al3 showed 
that chagasic patients who undergo glucose overload have 
a smaller increase in heart rate, blood pressure and insulin, 
which suggests a deficit in insulin production and action, or 
autonomic nervous system imbalance. 
A necropsy study in women with Chagas’ disease 
showed a deficit in the intrapancreatic neuron population 
and the presence of leukocyte perineuronal4. These results 
suggest a possible association between a lower number 
of intrapancreatic neuron and carbohydrate metabolism 
abnormalities, including hyperglycemia and diabetes. Insulin 
tolerance testing is an experiment that allows us to evaluate 
the hemodynamic profile and insulin sensitivity in healthy 
individuals and in individuals with different pathologies. 
ILH infusion is used to evaluate pancreatic response to fatty 
acids and the hemodynamic response to fatty acids. The aim 
of this study was to analyze the impact of insulin injection 
(bolus) and ILH infusion on hemodynamic, metabolic, and 
autonomic response in patients with the indeterminate form 
of Chagas’ disease. 
Introduction
Hypertension, obesity, insulin resistance and diabetes, 
a cluster of cardiovascular risk factors, are associated 
with increased morbidity and mortality. The mechanisms 
underlying insulin resistance, the metabolic and hemodynamic 
abnormalities associated with this condition, are not well 
established. However, it is well known that fatty acids have 
a relationship with insulin resistance and with hemodynamic 
abnormalities, such as increased blood pressure, heart rate, 
and decreased small vessel distensibility (impaired endothelial 
function)1. 
ILH infusion is a model of hyperlipidemia that permits 
an acute fatty acid increase in the blood. An increase in the 
sympathetic nervous system activity has been appointed as 
a possible mechanism for at least some of the hemodynamic 
alterations following acute hyperlipidemia. Information 
is lacking regarding the mechanism for the increase in 
sympathetic activity resulting from the increase in fatty 
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Methods
Twelve patients with the indeterminate form of Chagas’ 
disease (Ch) and 12 healthy volunteers (C) matched for age, 
sex, race, blood pressure and heart rate were evaluated. The 
study was approved by the Ethics Committee of the Hospital 
das Clínicas of São Paulo University.  All individuals signed an 
informed consent. 
Screening tests – the screening tests included biochemistry, 
electrocardiography, and echocardiography. After patients 
fasted for 12 hours; samples of blood were drawn for 
biochemistry analysis (glucose, triglycerides, total cholesterol, 
LDL-cholesterol, HDL-cholesterol, uric acid, sodium 
potassium, urea, creatinine) and hemography was performed 
using an automated hematology analyzer XT-2000ii-XT-1800ii 
(Sysmex Corporation, Kobe, Japan). Sodium, potassium, 
glucose, and triglycerides were measured through the selective 
electrode method (IMT-Dade Behring, Newark, USA). Uric 
acid, urea, and creatinine were measured using the absorption 
photometry technique (colorimetric method). Total cholesterol 
and HDL-cholesterol were measured using the enzymatic 
colorimetric method, and LDL-cholesterol was calculated 
according to the Friedewald equation. 
Electrocardiography – electrocardiography was performed 
with individuals in a supine position and a 12-channel model 
Page Writer 300i, 1770A (Philips, USA) EKG machine was used.
Echocardiography – echocardiographic images were 
acquired in a Sequoia device (Acuson Computed Sonography, 
Mountain View, CA) with multifrequency transducer (3V2C) 
and resources to obtain an M-mode echocardiogram, 
2-dimensional, conventional continuous and pulsed Doppler, 
color Doppler and tissue Doppler. Images were registered on 
an optic disc and analyzed later. Individuals were maintained 
in a lateral position. The electrocardiogram registered 
continuously on a monitor during the test. Conventional 
echocardiography was performed in all individuals. Correct 
positioning for image acquisition in 2-dimensional-guided 
M-mode echocardiography, continuous and pulsed Doppler, 
was according to the guidelines of the American Society of 
Echocardiography5.
 Insulin tolerance test – The individuals were admitted 
early in the morning after overnight fasting for the ITT. After 
admission, BP and heart rate were measured with the patient 
in the seated position before the I.V. (intravenous) line was 
started for ITT. Blood samples for biochemistry measurements 
were drawn before pushing I.V. insulin (0.05 UI/kg). Blood 
samples were drawn every 3 minutes from time zero to 15 
minutes. Blood glucose was measured every 3 minutes by 
Accu-Chek (Advantage, ROCHE), and the test was interrupted 
if blood glucose dropped to 50 mg/dL or less and/or if the 
individual experienced any sort of symptoms. After the last 
blood draw, the individuals were fed. Meals were ad libitum, 
caffeine-free, and high carbohydrate to return serum blood 
glucose to a safe level. Thirty minutes later, glucose control 
was repeated, and if normal, the individual was discharged. 
Intralipid® and heparin infusion – Plasma fatty acid and 
triglycerides were acutely elevated in the laboratory with an 
infusion of Intralipid® and heparin.  Intralipid® 20% (Baxter 
Healthcare Corporation, Glendale, CA) was infused at 0.8 
mL/m2/min. Heparin (1000 U bolus, followed by 200 U/h) 
was given to activate endothelial lipoprotein lipase and 
accelerate hydrolysis of fatty acids from the glycerol backbone 
of triglycerides. The infusion time was up to 3 hours. Blood 
samples were drawn at time zero, 90 and after 180 minutes 
for biochemistry measurements. Blood pressure was measured 
beat-to-beat (Finometer, FMS, Finapres Medical System BV, 
Holland) at baseline and during ILH infusion.
Pulse Interval Variability — Time-domain analysis consisted 
of calculating mean pulse interval (PI) or R-R interval (RR), 
followed by their variability as the standard deviation from 
its respective time series.  In the frequency-domain analysis, 
fast Fourier transforming methods were used to evaluate 
pulse interval and R-R interval variability.  The spectral bands, 
commonly used for humans, are very low frequency (VLF), 
0.0-0.04 Hz; LF, 0.04-0.15 Hz; HF, 0.15-0.4 Hz.  Spectral 
power for low- and high-frequency bands was calculated by 
power spectrum density integration within each frequency 
band width. The power density of each spectral component 
was calculated both in absolute values and in normalized units. 
The power in low and high frequencies for pulse interval was 
normalized by calculating the variance minus the power in very 
low frequency and was expressed in normalized units (nu). 
The sympathovagal balance was defined by the LF/HF ratio. 
The LF component of R-R variability was considered a marker 
of efferent sympathetic cardiac and vascular modulation, 
respectively, whereas the HF component of the R-R or pulse 
interval variability would reflect respiratory-driven vagal 
modulation to the sinoatrial node. Beat-to-beat values of R-R 
interval were used to estimate cardiac baroreflex sensitivity 
(BRS) through the spectral analysis, using the alpha index for 
the low-frequency band (0.04-0.15 Hz).
Baroreflex sensitivity – The sensitivity of the baroreceptor 
heart rate reflex was assessed throughout a beat-to-beat blood 
pressure register through the analysis of systolic blood pressure 
(SBP) and pulse interval (PI) variation with a time domain. Time 
domain parameters consisted of calculation of average values 
of PI, SBP, and the variability of pulse interval and systolic 
blood pressure quantified by standard deviation of each one 
(PI sd and SBP sd, respectively). Welch’s Periodogram Method 
assisted by the Matlab program (automatic detection of systolic 
events from blood pressure wave) was used to analyze SBP 
and PI in the frequency domain. Relevant band frequency for 
spectral analysis in humans is between zero and 0.4 Hz.  The 
spectral power was integrated in 3 bands of relevance: HF 
that is between 0.4 and 0.15 Hz; LF that is between 0.15 and 
0.04 Hz; VLF that is lower than 0.04 Hz, and the autonomic 
balance was calculated according to the LF/HF ratio.
The alpha index (baroreflex by spectral analysis) was 
calculated after the link between PI and SBP was checked by 
using the function of coherence in the frequency between 
0.15 and 0.4 Hz. Coherence value (K) higher than 0.5 was 
considered significant. 
Statistical analysis
The chi-square test was used to analyze nonnumeric data. 
Numeric variables were compared using Student’s t test. 
Pearson’s test was used to correlate different variables. The 
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means obtained in time domain (hemodynamic measures) were 
compared using General Linear Model — repeated measures. 
SPSS software (Chicago, IL, USA) was used to analyze data.  A 
P value < 0.05 was adopted as statistically significant. Data 
are shown as mean ± SD. Biochemical values, insulin and 
noradrenaline with nonparametric distribution were evaluated 
by the Wilcoxon signal test. The comparison between groups 
for these biochemical variables, including the nonparametric 
ones, was performed using the Mann-Whitney test6. 
Results
Demographic data are shown in Table 1. Baseline 
biochemistry data are shown in Table 2. Baseline insulin was 
higher (p<0.05) in Ch compared with the C group (29±60 vs 
6±20 µUI/mL, respectively) and increased significantly in both 
groups during ITT, mainly in C (from 6±20 to 114±6 µUI/mL). 
Plasma glucose decreased significantly in both groups 
after insulin bolus; it changed 40 mg/dL on average in both 
groups. Blood pressure and heart rate were similar in C and 
Ch groups. Systolic and diastolic BP increased significantly 
in the C group after insulin bolus (Figures 1a and 1b). Heart 
rate also increased significantly in the C group after insulin 
bolus (Figure 1c). 
The Ch group had higher baseline plasma noradrenaline at 
baseline compared with the C group; however, the C group 
had a significant increase in noradrenaline concentration 
after insulin bolus, but in the Ch group, noradrenaline did 
not differ (Figure 2). 
Triglyceride levels were similar in both groups at baseline 
and increased 473 mg/dL in the C group and 475 mg/
dL in the CH group.  Systolic and diastolic BP increased 
significantly in both groups during ILH infusion (Figures 3a 
and 3b). Baseline heart rate did not differ between groups 
and increased significantly in Ch compared with C during 
ILH infusion (Figure 3c). 
Noradrenaline concentration increased significantly in C 
(102±24 to 137±39 pg/mL, p<0.05) compared with Ch 
(157±91 to 179±131 pg/mL, p>0.05) during ILH infusion. 
Baseline LF/HF ratio, which indicates the sympathetic and 
parasympathetic component balance, was similar in both 
Table 1 – Demographic data of Control and Chagasic groups
Variables Control group n=12 Chagasic group  n=12 p-Value
Age (years) 32 ± 6 41 ± 8 NS
Sex (F/M) 8/4 8/4 NS
Race
10 white 10 white
NS
2 nonwhite 2 nonwhite
Weight (kg) 67 ± 10 61 ± 12 NS
Height (m) 1.67 ± 0.09 1.57 ± 0.15 NS
BMI (kg/m2) 23.87 ± 2.49 24.40 ± 2.16 NS
 F – Female; M – Male; BMI – Body mass index; NS - No significant.
Table 2 — Biochemistry data from Control and Chagasic groups
Variables Control group n=12 Chagasic group n=12 p-Value 
Hb (g%) 14.0 ± 1.2 13.3 ± 1.7 0.71
Ht (g%) 41.0 ± 3.0 41.0 ± 5.0 0.99
Glucose (mg/dL) 69.5 ± 10.1 75.4 ± 11.6 0.21
Urea (mg/dL) 31.1 ± 6.4 32.6 ± 8.7 0.23
Creatinine (mg/dL) 0.9 ± 0.2 0.8 ± 0.2 0.70
Sodium (mEq/L) 131.7 ± 2.7 140.3 ± 1.3 0.22
Potassium (mEq/L) 3.9 ± 0.5 4.2 ± 0.4 0.06
Uric acid (mEq/L) 4.1 ± 1.4 4.2 ± 1.2 0.85
Triglycerides (mg/dL) 96.6 ± 71.5 107.2 ± 89.9 0.66
Total cholesterol  (mg/dL) 174.0 ± 39.1 162.6 ± 27.4 0.87
LDL-C (mg/dL) 101.9 ± 30.3 94.9 ± 18.3 0.16
HDL-C (mg/dL) 50.9 ± 26.9 46.8 ± 11.1 0.36
Hb – hemoglobin e Ht – hematocrit
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Figure 1 – Systolic, diastolic BP, and heart rate (mean ± SD) at baseline and after ITT. 
Systolic BP
Before After
*p < 0.05 – Systolic BP increase in C group.
Control Group
Chagasic Group
(m
mH
g)
(m
mH
g)
Diastolic BP
Control Group
Chagasic Group
Before After
*p < 0.05 – Diastolic BP increase in C group.
Heart Rate
Before After
Control Group
Chagasic Group
(b
pm
)
*p < 0.05 – Heart rate increase in C group.
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groups at baseline and increased significantly during ILH 
infusion in C and Ch groups (Figure 4). 
At baseline and during ILH infusion, the Ch group had a 
higher LF/HF ratio, although it was not significant. Baseline 
baroreflex sensitivity was lower in the Ch group, and this 
difference was sustained during ILH infusion (Figure 5). 
Baroreflex sensitivity in the C group had a tendency to decline 
after 180 minutes of infusion and did not differ in the Ch group.
Discussion
In this case control study, 12 individuals with the indeterminate 
form of Chagas’ disease and 12 healthy volunteers matched for 
age, sex, race, body mass index, blood pressure, heart rate 
and biochemical variables were evaluated. The Ch group had 
baseline insulin and noradrenaline levels higher than those of 
the C group. 
There is no consensus in the literature regarding baseline 
plasma insulin in chagasic patients or insulin behavior after 
ITT. We observed a significant increase in insulin levels in the 
C group and a slight increase in chagasic patients during ITT. 
These results reinforce previous information regarding an 
impaired pancreatic response that resulted from a deficit in 
the intrapancreatic neuron population. The heterogeneous 
response of insulin to glucose overload in chagasic patients 
is well known3. A parasympathetic denervation and beta cell 
abnormalities have been discussed as possible explanations 
for these alterations in the metabolism of glucose in chagasic 
patients2. On the day of ITT, baseline glucose level was slightly 
lower in the Ch group. 
In a previous study, Guariento et al7 already observed 
the same situation in patients with the indeterminate form 
of Chagas’ disease. Glucose metabolism, including insulin 
release, is related, at least partly, to autonomic nervous 
system integrity. Chagas’ disease affects not only the 
parasympathetic nervous system, but also the sympathetic 
component of the autonomic nervous system. 
Regarding glucose, during ITT, insulin bolus resulted in a 
similar decline in blood glucose in the Ch and C groups. In 
relation to the hemodynamic responses, the similar decrease 
in glucose in both groups resulted in a significant increase in 
the systolic and diastolic BP, and in the heart rate in the C 
group after insulin bolus, compared with that in the Ch group. 
This hemodynamic response to insulin during ITT suggests 
an increase in sympathetic activity, and this response is 
probably blunted in chagasic patients once this population 
is considered denervated. In a study involving chagasic 
patients, Guariento et al7 showed an impaired BP and heart 
rate response to a glucose overload, a stimuli for insulin 
production. 
Although the baseline plasma noradrenaline was higher in 
the Ch group on the day of ITT, the response to insulin bolus 
resulted in a significant increase in noradrenaline in the C 
group and did not change in the Ch group. It also suggests a 
blunted sympathetic response in chagasic patients, because 
this population has the autonomic nervous system affected 
at different degrees and in different locations. 
According to previous studies8, the main part of the 
autonomic nervous system affected in chagasic patients is the 
parasympathetic system. However, Chagas’ disease can affect 
Figure 2 – Plasma noradrenaline (mean ± SD) at baseline and after insulin bolus during ITT.
Control group 
Chagasic group 
Before After
*p < 0.05 – C group vs. CH group at baseline.
**p < 0.05 – C before vs. after insulin bolus.
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Fig. 3 – Variação da pressão arterial sistólica e diastólica e frequência cardíaca (média ± DP) durante infusão de ILH a 0, 90 e 180 minutos.
Systolic BP
Control Group
Chagasic Group
*p < 0.05 – Systolic BP increase in C group (time 180 vs. Time 0)
**p < 0.05 – Systolic BP increase in CH group (time 180 vs. Time 0)
Diastolic BP
mg
Hg
mg
Hg
Control Group
Chagasic Group
*p < 0.05 – Diastolic BP increase in C group (time 180 vs. Time 0)
**p < 0.05 – Diastolic BP increase in CH group (time 180 vs. Time 0)
Heart Rate
Control Group
Chagasic Group
*p < 0.05 – Heart rate increase in C group (time 180 vs. Time 0)
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Figure 4 – Low frequency (LF) component (mean ± SD) in normalized potency (n.u.), high frequency (HF) component (mean ± SD) in normalized potency (n.u.), and LF/HF 
ratio components during ILH infusion. 
Figure 5 – Baroreflex sensitivity at baseline and during the ILH infusion.
the brain, and the main mechanism for noradrenaline release 
mediated by insulin depends on the central mechanism 
(hypothalamus stimulus)9.  
On the day of ILH infusion, the baseline triglycerides 
were similar in both groups. After 3 hours of ILH infusion, 
triglycerides increased significantly, and this increase was 
similar in both the C and Ch groups. The main aim of 
ILH infusion was to increase the blood concentration of 
triglycerides and consequently the fatty acids. 
Friedberg et al10 have already shown a good correlation 
between triglycerides and fatty acids in the circulation. 
Baseline blood pressure and heart rate before ILH infusion 
were similar in both groups. ILH infusion resulted in a 
significant increase in systolic and diastolic blood pressure in 
the C and Ch groups. The increase in heart rate after the ILH 
infusion in the Ch group was significant, while the change in 
the C group was slight. 
Gadegbeku et al11 showed that ILH impairs baroreflex 
sensitivity in lean and obese patients. Because baroreflex 
LF/HF ratio
Chagasic group
Control group
*p < 0.05 – LH/HF ratio in C group C (90 min. Baseline)
**p < 0.05 – LH/HF ratio in CH group (90 min. Baseline)
***p < 0.05 – LH/HF ratio in C group (180 min. Vs. 90 min)
****p < 0.05 – LH/HF ratio in CH group (180 min. Vs. 90 min)
alpha index
Chagasic group
Control group
*p < 0.05 – CH group vs. C group at baseline
**p < 0.05 – CH group vs. C group at 90 min
***p < 0.05 – CH group vs. C group at 180 min
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sensitivity is affected in chagasic patients12, the increase in heart 
rate in the presence of increased blood pressure may reflect an 
impairment in an already blunted reflex. Nonetheless, ILH is 
related to an increase in heart rate in healthy individuals1.
As discussed before13, the  sympathetic nervous system 
activity seems to be an important mechanism in metabolic 
syndrome, and insulin alteration can be an abnormality, among 
several others, that can explain the sympathetic hyperactivity. 
We found baseline plasma insulin higher in the Ch group, and 
noradrenaline was higher in this group, supporting the idea that 
insulin alteration is related to the sympathetic activity. We must 
emphasize that chagasic patients are not the best model to be 
used for this association, and further studies using this model 
or others can support or contest this result. On the other hand, 
insulin did not increase after ITT testing. 
In relation to the ILH infusion, a significant increase in plasma 
insulin occurred in the C group and did not differ in the Ch group. 
According to the literature, free fatty acids increased insulin in 
healthy individuals. Even though there is controversy regarding 
this issue, considering that the pancreas of chagasic patients 
is denervated, this can reflect the absence of enervation and 
the autonomic abnormalities frequently observed in chagasic 
patients. However, these data are new and need more studies, 
using the same model, to be confirmed.
 Plasma noradrenaline at baseline was higher in the Ch group 
than in the C group, and the ILH infusion resulted in a significant 
increase in the C group while it did not change in the CH 
group, an observable fact that can be explained by autonomic 
abnormalities commonly present in patients with Chagas’ disease. 
Considering that chagasic patients had an increase in blood 
pressure and heart rate, the mechanism for this hemodynamic 
change should be independent of the autonomic nervous system. 
Egan13 in a review article mentioned the importance of alpha 
receptor activation by oleate in rats. It suggests that a possible 
mechanism of sympathetic activation resulted from ILH infusion. 
Spectral analysis was also performed in this study to evaluate the 
sympathetic and parasympathetic components at baseline and 
during ILH infusion. 
Using this method, Paolisso et al14 showed an increase in 
the LF component in healthy individuals who underwent ILH 
infusion. In this study, the baseline LF component was slightly 
higher in the Ch group, but did not achieve statistical significance. 
This small difference sustained during ILH infusion and an 
intragroup increase occurred at minutes 90 and 180 compared 
with baseline. As for the HF component, at baseline it was 
slightly lower in the C group compared with the Ch group, and 
during ILH infusion this component decreased significantly in 
both groups. These data corroborate the previous finding of 
impairment in parasympathetic activity in chagasic patients. L/F 
ratio behavior was similar in both groups and also reflected the 
profile of the LF and HF components at baseline and during 
ILH infusion.   
Baseline baroreflex sensitivity was significantly lower in the 
Ch group. This difference was maintained during ILH infusion. 
The C group had a tendency towards  decrease in baroreflex 
sensitivity during ILH infusion, a phenomenon already observed 
by Gadegbeku et al11 Although acute hyperlipidemia resulting 
from ILH infusion has been tested in different experimental and 
clinical models, this is the first time it has been tested in patients 
with the indeterminate form of Chagas’ disease, a model of 
autonomic system imbalance. New studies are necessary to 
better understand the effects of ILH in the neural control of 
blood pressure and heart rate, not only in chagasic but also in 
healthy individuals.  
In conclusion, our data show higher sympathetic activity in 
patients with the indeterminate form of Chagas’ disease, lower 
blood pressure response in chagasic patients during ITT, a 
significant increase in the blood pressure and sympathetic activity 
in chagasic patients and controls during Intralipid® and heparin 
infusion, and  decreased baroreflex sensitivity in chagasic patients 
and controls during Intralipid® and heparin infusion. 
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